Saturday 17 October 2026 Export TCRX’s income statement to Excel — free account

TScan Therapeutics, Inc.

TScan Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.3 million, up 266.7% from fiscal 2024. In the quarter to June 2026, revenue fell 65.8%, EPS grew 17.9%, free cash flow grew 19.0% and total debt rose 1.50%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.23 0.01 −4.17%

Follow TCRX

Alert me

Market cap: $16.2M
P/E: 0.0×
Fwd P/E: −1.1×
Dividend yield: —
F-score: 2/9
Altman Z: −3.54
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	17.91	14.36	12.57	28.05
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(4.62)	(5.40)	(4.06)	(7.28)
P/B ratio Full definition →	1.85	1.35	1.05	1.64
Price to Tangible BV Full definition →	1.85	1.35	1.05	1.64
EV/Sales Full definition →	8.43	5.05	1.96	11.23
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(0.52)	(0.38)	(0.15)	(0.72)
EV/FCF Full definition →	(0.51)	(0.37)	(0.14)	(0.70)
Quick Ratio Full definition →	3.23	6.41	8.15	6.32
Current Ratio Full definition →	3.37	6.65	8.41	6.44
Net Debt/EBITDA Full definition →	2.26	3.35	5.18	4.19
Debt/Assets Full definition →	19.12%	16.17%	14.22%	12.36%
Debt/Equity Full definition →	0.47	0.34	0.26	0.23
Asset Turnover Full definition →	0.03	0.03	0.03	0.03
Operating CF/Net income Full definition →	0.91	0.85	1.39	0.91
Capex/Depreciation Full definition →	(0.67)	(0.10)	(0.24)	(1.86)
Interest Coverage Full definition →	(43.62)	(42.29)	(33.99)	(53.01)
Research and Development Expense of Revenue Full definition →	2,226.64%	2,230.55%	780.64%	1,262.01%
Selling, General and Administrative Expense of Revenue Full definition →	774.69%	836.76%	248.77%	313.58%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	224.26%	251.02%	78.22%	119.91%
Graham Net Nets Full definition →	0.02	0.21	0.40	0.30
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(92.86%)	(95.05%)	(100.00%)	(61.54%)
Free Cash Flow Yield Full definition →	(92.98%)	(95.23%)	(107.67%)	(57.49%)
Revenue per Share Full definition →	0.01	0.01	0.02	0.02
Operating CF per Share Full definition →	(0.21)	(0.19)	(0.25)	(0.25)
Capex per Share Full definition →	0.00	0.00	0.00	(0.01)
Free Cash Flow per Share Full definition →	(0.22)	(0.19)	(0.25)	(0.26)
Cash per Share Full definition →	0.77	0.99	1.17	1.42
Shareholders Equity per Share Full definition →	0.53	0.75	0.95	1.11
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	0.53	0.75	0.95	1.11
Free Cash Flow Full definition →	(28.00)	(24.35)	(32.17)	(33.89)
Working Capital Full definition →	73.44	112.80	138.51	158.96
Capital Expenditures Full definition →	(0.46)	(0.07)	(0.17)	(1.42)
Net Current Asset Value Full definition →	1.97	27.70	51.54	69.96
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.44	0.07	0.07	0.57
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Payables Full definition →	3.83	3.63	2.76	5.00
Average Assets Full definition →	235.01	267.35	299.95	305.13
Average Common Equity Full definition →	122.87	153.56	182.05	186.55

Show all line items

Columns are period end dates

Stockrow Weekly